32 related articles for article (PubMed ID: 7391657)
1. A Review on Secondary Immune Thrombocytopenia in Malaysia.
Zahidin MA; Mohd Noor NH; Johan MF; Abdullah AD; Zulkafli Z; Edinur HA
Healthcare (Basel); 2021 Dec; 10(1):. PubMed ID: 35052202
[TBL] [Abstract][Full Text] [Related]
2. Breast carcinoma presenting as immune thrombocytopenic purpura.
Wahid FS; Fun LC; Keng CS; Ismail F
Int J Hematol; 2001 Apr; 73(3):399-400. PubMed ID: 11345211
[No Abstract] [Full Text] [Related]
3. Modified recalcification time (MRT): a sensitive cancer test? Review of the evidence.
Spillert CR; Lazaro EJ
J Natl Med Assoc; 1995 Sep; 87(9):687-92. PubMed ID: 9583965
[TBL] [Abstract][Full Text] [Related]
4. Hypercoagulability after immunotherapy with Corynebacterium parvum in man.
Harenberg J; Baumgärtner A; Fritze D; Zimmermann R
Blut; 1982 Apr; 44(4):241-7. PubMed ID: 7082858
[TBL] [Abstract][Full Text] [Related]
5. Transformation-enhancing activity of gelatin-binding fragments of fibronectin.
De Petro G; Barlati S; Vartio T; Vaheri A
Proc Natl Acad Sci U S A; 1981 Aug; 78(8):4965-9. PubMed ID: 6458038
[TBL] [Abstract][Full Text] [Related]
6. Metastatic brain tumour and fibrinopeptides.
Yumitori K; Handa H; Teraura T; Yamashita J; Yamamura K
Acta Neurochir (Wien); 1987; 89(1-2):43-7. PubMed ID: 3434341
[TBL] [Abstract][Full Text] [Related]
7. [Immunologic and functional protein C determination in various internal diseases].
Zurborn KH; Broers H; Kirch W; Jäger N; Bruhn HD
Klin Wochenschr; 1987 Oct; 65(19):906-11. PubMed ID: 3431026
[TBL] [Abstract][Full Text] [Related]
8. Haemostasis in malignant disease.
Auger MJ; Mackie MJ
J R Coll Physicians Lond; 1988 Apr; 22(2):74-9. PubMed ID: 3294389
[No Abstract] [Full Text] [Related]
9. Whole blood procoagulant activity in breast and colorectal cancer.
Mellor H; Taylor I; Roath S; Francis JL
J Clin Pathol; 1989 May; 42(5):489-94. PubMed ID: 2732342
[TBL] [Abstract][Full Text] [Related]
10. Specificity of tumor markers (CEA, GICA, TPA, alpha-FP, FpA, gamma-GT) for the diagnosis of hepatic metastases from large bowel cancers.
Abbasciano V; Levato F; Zavagli G
Med Oncol Tumor Pharmacother; 1989; 6(2):129-32. PubMed ID: 2473362
[TBL] [Abstract][Full Text] [Related]
11. Abnormal haemostasis in small cell lung cancer.
Milroy R; Douglas JT; Campbell J; Carter R; Lowe GD; Banham SW
Thorax; 1988 Dec; 43(12):978-81. PubMed ID: 2467397
[TBL] [Abstract][Full Text] [Related]
12. Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo.
Nierodzik ML; Plotkin A; Kajumo F; Karpatkin S
J Clin Invest; 1991 Jan; 87(1):229-36. PubMed ID: 1845869
[TBL] [Abstract][Full Text] [Related]
13. Hemostatic alterations in cancer patients.
Rickles FR; Levine M; Edwards RL
Cancer Metastasis Rev; 1992 Nov; 11(3-4):237-48. PubMed ID: 1423816
[TBL] [Abstract][Full Text] [Related]
14. Factor IXi-antithrombin (IXiAT) and thrombin-antithrombin (TAT) complexes in lung cancer patients.
Kemkes-Matthes B; Bleyl H
Ann Hematol; 1992 Jan; 64(1):35-9. PubMed ID: 1310878
[TBL] [Abstract][Full Text] [Related]
15. Significance of plasma fibrinopeptide A (fpA) in patients with malignancy.
Peuscher FW; Cleton FJ; Armstrong L; Stoepman-van Dalen EA; van Mourik JA; van Aken WG
J Lab Clin Med; 1980 Jul; 96(1):5-14. PubMed ID: 7391657
[TBL] [Abstract][Full Text] [Related]
16. High fibrinopeptide A (FPA) levels in acute non-lymphocytic leukemia are reduced by heparin administration.
Gugliotta L; Viganò S; D'Angelo A; Guarini A; Tura S; Mannucci PM
Thromb Haemost; 1984 Dec; 52(3):301-4. PubMed ID: 6531754
[TBL] [Abstract][Full Text] [Related]
17. [Fibrinogen metabolism and plasma fibrinopeptide A in disseminated neoplasms].
Mombelli G; Roux A; Hofmann V; Straub PW
Schweiz Med Wochenschr; 1979 Dec; 109(47):1901. PubMed ID: 531571
[TBL] [Abstract][Full Text] [Related]
18. [Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases].
Murakoshi T
Hokkaido Igaku Zasshi; 1982 May; 57(3):351-63. PubMed ID: 6957368
[TBL] [Abstract][Full Text] [Related]
19. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
